A detailed history of Wimmer Associates 1, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 1,385 shares of LLY stock, worth $1.1 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
1,385
Previous 1,392 0.5%
Holding current value
$1.1 Million
Previous $1.26 Million 2.62%
% of portfolio
0.61%
Previous 0.65%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $5,404 - $6,720
-7 Reduced 0.5%
1,385 $1.23 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $18,121 - $22,726
25 Added 1.83%
1,392 $1.26 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $14,705 - $17,335
-28 Reduced 2.01%
1,367 $796,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $47,817 - $65,923
110 Added 8.56%
1,395 $749,000
Q1 2023

May 16, 2023

BUY
$310.63 - $364.82 $26,403 - $31,009
85 Added 7.08%
1,285 $441,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $12,862 - $14,986
-40 Reduced 3.23%
1,200 $439,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $1,482 - $1,689
-5 Reduced 0.4%
1,240 $449,000
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $12,542 - $14,727
45 Added 3.75%
1,245 $404,000
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $49,284 - $61,248
-210 Reduced 14.89%
1,200 $344,000
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $9,037 - $11,699
55 Added 4.06%
1,410 $263,000
Q3 2020

Dec 03, 2020

BUY
$146.22 - $169.13 $198,128 - $229,171
1,355 New
1,355 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wimmer Associates 1, LLC Portfolio

Follow Wimmer Associates 1, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.